Dr. Scott Gottlieb told CNBC Wednesday that the United States could have around 300,000 coronavirus deaths by the end of the year if current trends persisted. That would be more than double the current total. “Right now we have about 1,000 victims a day, so if we don’t change that …
Read More »
While markets reacted positively this week to promising news of possible developing coronavirus vaccines, a leading economist warned that the economic impact of the pandemic will be here for a long time. A large number of small businesses that closed in March when restrictions on social movements went into effect …
Read More »
[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.]
Read More »
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »
The UK government said on Monday it has secured early access to 90 million doses of vaccines from two potential COVID-19 vaccines developed by a partnership between Germany’s BioNTech and US drug maker Pfizer, as well as one by the group. French Valneva. The business ministry said it had signed …
Read More »